0001179110-18-006906.txt : 20180516
0001179110-18-006906.hdr.sgml : 20180516
20180516173020
ACCESSION NUMBER: 0001179110-18-006906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180514
FILED AS OF DATE: 20180516
DATE AS OF CHANGE: 20180516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dreier Ashley
CENTRAL INDEX KEY: 0001614957
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 18841015
MAIL ADDRESS:
STREET 1: 15 W. SCENIC POINTE DR., STE. 100
CITY: DRAPER
STATE: UT
ZIP: 84020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY INC
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
4
1
edgar.xml
FORM 4 -
X0306
4
2018-05-14
0
0001428336
HEALTHEQUITY INC
HQY
0001614957
Dreier Ashley
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER
UT
84020
0
1
0
0
Executive, VP, CTO and CIO
Common Stock
2018-05-14
4
M
0
16750
1.50
A
49939
D
Common Stock
2018-05-14
4
M
0
3000
14.00
A
52939
D
Common Stock
2018-05-14
4
M
0
16250
24.36
A
69189
D
Common Stock
2018-05-14
4
S
0
32300
70.8475
D
36889
D
Common Stock
2018-05-14
4
S
0
3700
71.7676
D
33189
D
Stock Option (right to buy)
1.50
2018-05-14
4
M
0
16750
0
D
2023-05-09
Common Stock
16750
0
D
Stock Option (right to buy)
14
2018-05-14
4
M
0
3000
0
D
2024-07-30
Common Stock
3000
0
D
Stock Option (right to buy)
24.36
2018-05-14
4
M
0
16250
0
D
2026-03-23
Common Stock
16250
32500
D
The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017, as amended on April 12, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.36 to $71.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.38 to $72.24, inclusive.
The option is immediately exercisable.
The option becomes exercisable as to 32,500 shares in two equal installments on March 23, 2019 and 2020.
/s/ Ashley Dreier
2018-05-15